mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.02 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.02 |